348 related articles for article (PubMed ID: 12387980)
21. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
Imdahl A; Schöffel U; Ruf G; Hopf UT
Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
[TBL] [Abstract][Full Text] [Related]
22. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.
Chua YJ; Cunningham D
Ann Surg Oncol; 2007 Oct; 14(10):2687-90. PubMed ID: 17653804
[No Abstract] [Full Text] [Related]
23. [Epidermoid cancer of the esophagus: role of radiotherapy and chemotherapy].
Delouche D; Haefliger JM
Rev Med Suisse Romande; 1998 Mar; 118(3):227-34. PubMed ID: 9594596
[No Abstract] [Full Text] [Related]
24. Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma.
Lew JI; Gooding WE; Ribeiro U; Safatle-Ribeiro AV; Posner MC
Arch Surg; 2001 Jul; 136(7):737-42; discussion 743. PubMed ID: 11448381
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma.
Orringer MB; Forastiere AA; Perez-Tamayo C; Urba S; Takasugi BJ; Bromberg J
Ann Thorac Surg; 1990 Mar; 49(3):348-54; discussion 354-5. PubMed ID: 2106845
[TBL] [Abstract][Full Text] [Related]
26. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Kersting S; Konopke R; Dittert D; Distler M; Rückert F; Gastmeier J; Baretton GB; Saeger HD
J Gastroenterol Hepatol; 2009 May; 24(5):886-95. PubMed ID: 19655439
[TBL] [Abstract][Full Text] [Related]
27. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
Briasoulis E; Fatouros M; Roukos DH
Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
[No Abstract] [Full Text] [Related]
28. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.
Burmeister BH; Denham JW; O'Brien M; Jamieson GG; Gill PG; Devitt P; Yeoh E; Hamilton CS; Ackland SP; Lamb DS
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):997-1006. PubMed ID: 7607974
[TBL] [Abstract][Full Text] [Related]
29. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus.
Stockeld D; Tennvall J; Wagenius G; Albertsson M; Backman L; Brodin O; Cwikiel M; Granström L; Gustafsson G; Gustavsson S; Hambraeus G; Lewensohn R; Sjöstedt S; Strander H; Aberg B; Fagerberg J
Acta Oncol; 2001; 40(5):566-73. PubMed ID: 11669327
[TBL] [Abstract][Full Text] [Related]
30. [No improvement of prognosis by neoadjuvant chemotherapy alone in operable esophageal carcinoma].
Fietkau R
Strahlenther Onkol; 1999 May; 175(5):251-2. PubMed ID: 10356618
[No Abstract] [Full Text] [Related]
31. [Chemotherapy for the patients with esophageal cancer].
Ando N; Shih CH
Nihon Geka Gakkai Zasshi; 2002 Apr; 103(4):359-63. PubMed ID: 11993225
[TBL] [Abstract][Full Text] [Related]
32. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.
Kelsen DP; Winter KA; Gunderson LL; Mortimer J; Estes NC; Haller DG; Ajani JA; Kocha W; Minsky BD; Roth JA; Willett CG; ;
J Clin Oncol; 2007 Aug; 25(24):3719-25. PubMed ID: 17704421
[TBL] [Abstract][Full Text] [Related]
33. The clinical efficacy of neoadjuvant chemotherapy in squamous esophageal cancer: a prospective nonrandomized study of pulse and continuous-infusion regimens with Cisplatin and 5-Fluorouracil.
Chan AC; Lee DW; Griffith JF; Leung SF; Lam YH; Lam CC; Lau JY; Ng EK; Chung SC
Ann Surg Oncol; 2002 Aug; 9(7):617-24. PubMed ID: 12167574
[TBL] [Abstract][Full Text] [Related]
34. Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy.
Hirst J; Smithers BM; Gotley DC; Thomas J; Barbour A
Ann Surg Oncol; 2011 Jun; 18(6):1766-74. PubMed ID: 21213056
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus.
Carey RW; Hilgenberg AD; Wilkins EW; Choi NC; Mathisen DJ; Grillo HC; Wain JC; Logan DL; Bromberg C
Cancer Invest; 1993; 11(2):99-105. PubMed ID: 8462027
[TBL] [Abstract][Full Text] [Related]
36. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
37. Outcomes from chemoradiotherapy for patients with esophageal cancer.
Pantling AZ; Gossage JA; Mamidanna R; Newman G; Robinson A; Manifold DK; Hale PC
Dis Esophagus; 2011 Apr; 24(3):172-6. PubMed ID: 21073614
[TBL] [Abstract][Full Text] [Related]
38. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
39. Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study.
Wright CD; Wain JC; Lynch TJ; Choi NC; Grossbard ML; Carey RW; Moncure AC; Grillo HC; Mathisen DJ
J Thorac Cardiovasc Surg; 1997 Nov; 114(5):811-5; discussion 816. PubMed ID: 9375611
[TBL] [Abstract][Full Text] [Related]
40. Outcomes after trimodality therapy for esophageal cancer: the impact of histology on failure patterns.
Koshy M; Greenwald BD; Hausner P; Krasna MJ; Horiba N; Battafarano RJ; Burrows W; Suntharalingam M
Am J Clin Oncol; 2011 Jun; 34(3):259-64. PubMed ID: 20686405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
